VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
IRLA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
IRLAIRulya Therapeutics Inc.
$40.59$39M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksIRLAQuarterly Financials

IRulya Therapeutics Inc. (IRLA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

IRulya Therapeutics Inc. (IRLA) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

IRLA Income Statement

Quarterly statement

IRLA Income Statement

IRulya Therapeutics Inc. (IRLA) annual income statement — 9-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold15K036K0035K016K000304K00000000
COGS % of Revenue--------------------
Gross Profit-15K0-36K00-35K0-16K000-304K00000000
Gross Margin %--------------------
Gross Profit Growth %-100%-100%----------------
Operating Expenses14.87M79.78M11.08M19.35M13.43M9.86M14.86M10.09M5.86M28.19M11.22M8.04M6.09M5.58M12.96M6.32M7.62M16.26M21.86M23.54M
OpEx % of Revenue--------------------
Selling, General & Admin9.02M16.63M4.27M3.63M3.28M3.34M4.79M4.27M3.63M4.7M4.97M4.61M4.66M4.23M3.83M3.55M4.34M9.06M9.11M8.33M
SG&A % of Revenue--------------------
Research & Development5.85M5.46M6.84M12.6M8.08M6.55M8.14M5.83M4.92M4.15M3.7M3.43M1.43M1.35M3.23M2.77M2.45M7.2M12.76M15.21M
R&D % of Revenue--------------------
Other Operating Expenses01000K-36K1000K1000K-35K1000K0-1000K1000K1000K0001000K0825K000
Operating Income-14.87M-79.78M-11.11M-19.35M-13.43M-9.89M-14.86M-10.11M-5.86M-28.19M-11.22M-8.34M-6.09M-5.58M-12.96M-6.32M-7.62M-16.26M-21.86M-23.54M
Operating Margin %--------------------
Operating Income Growth %-10.74%-706.29%25.21%-91.44%-129.06%64.9%----13.41%-32.03%20.03%65.65%40.74%73.16%64.85%25.36%6.22%-12.91%
EBITDA-14.86M-79.74M-11.08M-19.31M-13.39M-9.86M-14.83M-10.09M-5.78M-28.15M-11.18M-8.04M-5.35M-5.58M-12.94M-6.28M-7.58M-16.17M-21.82M-23.46M
EBITDA Margin %--------------------
EBITDA Growth %-10.93%-708.73%25.29%-91.36%-131.85%64.97%----13.61%-28.07%29.41%65.48%40.71%73.24%64.89%25.45%6.04%-12.97%
D&A (Non-Cash Add-back)15K41K36K39K36K35K32K16K86K44K40K304K01K17K42K40K84K38K84K
EBIT-14.87M-75.41M30.57M-16.24M-11.36M-15.98M-12.93M-12.45M-8.55M-8.84M-8.67M-8.84M-5.35M-4.89M-7.06M-5.53M-6.79M-16.85M-21.64M-23.4M
Net Interest Income1.02M584K160K227K300K311K406K536K683K823K887K1.01M959K805K700K536K315K145K72K105K
Interest Income1.02M584K160K227K300K311K406K536K683K823K887K1.01M959K805K700K536K315K145K72K105K
Interest Expense00000000000000000000
Other Income/Expense-13.17M4.37M41.69M-16.96M-58K-6.09M-125K-2.34M384K499K100K-500K743K698K454K785K-301K-590K222K145K
Pretax Income-28.05M-75.41M30.57M-36.31M-13.49M-15.98M-14.98M-12.45M-5.48M-27.69M-11.12M-8.84M-5.35M-4.89M-12.5M-5.53M-7.92M-16.85M-21.64M-23.4M
Pretax Margin %--------------------
Income Tax-302K75K-5.34M3.15M-46K67K47K7K13K36K31K51K00-248K00-284K00
Effective Tax Rate %1.08%-0.1%-17.46%-8.66%0.34%-0.42%-0.31%-0.06%-0.24%-0.13%-0.28%-0.58%0%0%1.98%0%0%1.69%0%0%
Net Income-27.74M-75.49M35.91M-39.46M-13.44M-16.05M-15.03M-12.46M-5.49M-27.73M-11.15M-8.89M-5.35M-4.89M-12.25M-5.53M-7.92M-16.56M-21.64M-23.4M
Net Margin %--------------------
Net Income Growth %-106.4%-370.36%338.94%-216.73%-144.76%42.12%----9.02%-60.72%32.45%70.5%43.38%76.35%63.51%23.86%6.26%-13.84%
Net Income (Continuing)-27.74M-75.49M35.91M-39.46M-13.44M-16.05M-15.03M-12.46M-5.49M-27.73M-11.15M-8.89M-5.35M-4.89M-12.25M-5.53M-7.92M-16.56M-21.64M-23.4M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-2.31-12.31143.40-150.00-50.00-68.00-68.00-56.00-26.00-128.00-52.00-44.00-30.00-28.00-68.00-32.00-46.00-102.00-142.00-158.00
EPS Growth %95.38%81.9%310.88%-167.86%-92.31%46.88%----23.53%-37.5%34.78%72.55%52.11%79.75%68.49%31.08%8.97%-12.86%
EPS (Basic)-2.31-12.31143.40-150.00-50.00-68.00-68.00-56.00-26.00-128.00-52.00-44.00-30.00-28.00-68.00-32.00-46.00-102.00-142.00-158.00
Diluted Shares Outstanding12M6.13M250.49K250.49K269.76K233.43K219.71K216.31K215.82K215.48K215.05K204.87K180.37K179.59K179.28K180.68K178.06K162.34K150.67K148.84K
Basic Shares Outstanding12M6.13M250.49K250.49K269.76K233.43K219.71K216.31K215.82K215.48K215.05K204.87K180.37K179.59K179.28K180.68K178.06K162.34K150.67K148.84K
Dividend Payout Ratio--------------------